Bristol-Myers Squibb To Take Part In Goldman Sachs Healthcare CEOs Unscripted Conference

Bristol-Myers Squibb Company (NYSE:BMY) announced today that it will take part in Goldman Sachs Healthcare CEOs Unscripted Conference on Tuesday, January 7, 2014, in Boston. Lamberto Andreotti, chief executive officer, will answer questions about the company at 10:15 a.m. EST.

Investors and the general public are invited to listen to a live webcast of the session at An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit or follow us on Twitter at

Copyright Business Wire 2010

If you liked this article you might like

Bristol-Myers Squibb Stock Still a Beast?

There Are Good Opportunities in Stock Picking

Halozyme Jumps on Immuno-Oncology Deal with Bristol-Myers

Achillion Shares Are Plunging on Termination of Hepatitis C Pact